← Back to headlines
Rigel Forecasts $275M-$290M Total Revenue for 2026 Amid Debt Restructuring
Rigel Pharmaceuticals projects total revenue of $275 million to $290 million for 2026, alongside efforts to restructure its debt and regain RIPK1 rights.
6 May, 11:52 — 6 May, 11:52
Sources
Showing 1 of 1 sources
